General Information
Revision date
2019-07-01
Product name
Celecoxib
CAS No.
169590-42-5
Icons in SDS
Company Information
company name
LC Laboratories
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H302+H312+H332
Hazard statements
Code
Statements
H302+H312+H332
Harmful if swallowed, in contact with skin or if inhaled
Section 2
Hazard statements
pharmaceutically active substance Substance Class Identifier: Tumorigen; Drug; Human Data May be harmful if swallowed, inhaled, or by skin absorption Ingestion may result in gastrointestinal effects (nausea, abdominal pain, dyspepsia (heartburn), bleeding, ulceration, and perforation), peripheral edema (swelling of face/extremities), hives, urticaria (redness and swelling of the skin), rash, chills, yellowing of skin and eyes, headache, dizziness, vomiting, diarrhea, insomnia, hypertension (increase in blood pressure), respiratory infection, chest pain, myocardial infarction (heart attack), stroke, congestive heart failure, liver effects, kidney effects, changes in blood cell levels, Stevens Johnson Syndrome (life-threatening skin condition), and prolonged bleeding time Serious allergic reactions, including anaphylaxis, have been reported; individuals with known hypersensitivity or allergic reaction to other NSAID family members or sulfonamides should avoid exposure May damage fertility or the unborn child; pregnant and nursing women should avoid exposure Toxic to aquatic life Exposure may cause irritation of the skin, eyes, and respiratory tract H302+312+332 - Harmful if swallowed, in contact with skin or if inhaled
Signal word
Danger
Precautionary statements
P2562 - Do not get in eyes, on skin or on clothing WARNING For Laboratory Research Use Only
